Patient Leaflet Updated 24-May-2023 | AstraZeneca UK Limited
Symbicort, 200 micrograms/6 micrograms per actuation, pressurised inhalation, suspension
Symbicort® 200 micrograms/6 micrograms per actuation pressurised inhalation, suspension
budesonide/formoterol fumarate dihydrate
1. What Symbicort is and what it is used for
2. What you need to know before you use Symbicort
3. How to use Symbicort
4. Possible side effects
5. How to store Symbicort
6. Contents of the pack and other information
Symbicort is an inhaler that is used to treat the symptoms of Chronic Obstructive Pulmonary Disease (COPD) in adults aged 18 and older. COPD is a long-term disease of the airways in the lungs, which is often caused by cigarette smoking. Symbicort contains two different medicines: budesonide and formoterol fumarate dihydrate.
Do not use this medicine as a “reliever” inhaler.
Talk to your doctor or pharmacist before using Symbicort if:
Contact your doctor if you experience blurred vision or other visual disturbances.
Symbicort is not recommended for children and adolescents under 18 years.
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
In particular, tell your doctor or pharmacist if you are using any of the following medicines:
If any of the above applies to you, or if you are not sure, talk to your doctor or pharmacist before using Symbicort.
Also tell your doctor or pharmacist if you are going to have a general anaesthetic for an operation or for dental work.
Symbicort has no or negligible effect on your ability to drive or to use tools or machines.
The usual dose is 2 inhalations twice a day. Symbicort is not recommended for children or adolescents under 18 years of age.
If you have been taking steroid tablets for your COPD, your doctor may reduce the number of tablets that you take, once you start to use Symbicort. If you have been taking oral steroid tablets for a long time, your doctor may want you to have blood tests from time to time. When reducing oral steroid tablets, you may feel generally unwell even though your chest symptoms may be improving. You might experience symptoms such as a stuffy or runny nose, weakness or joint or muscle pain and rash (eczema). If any of these symptoms bother you, or if symptoms such as headache, tiredness, nausea (feeling sick) or vomiting (being sick) occur, please contact your doctor immediately. You may need to take other medication if you develop allergic or arthritic symptoms. You should speak to your doctor if you are concerned as to whether you should continue to use Symbicort.
Your doctor may consider adding steroid tablets to your usual treatment during periods of stress (for example, when you have a chest infection or before an operation).
If you feel you are getting breathless or wheezy while using Symbicort, you should continue to use Symbicort but go to see your doctor as soon as possible, as you may need additional treatment.
Contact your doctor immediately if:
Your doctor may also prescribe other bronchodilator drugs, for example anticholinergics (such as tiotropium or ipratropium bromide) for your COPD disease.
You need to prepare your inhaler for use in the following situations:
To prepare your inhaler for use, follow the instructions below:
1. Shake the inhaler well for at least 5 seconds to mix the contents of the aerosol canister.
2. Remove the mouthpiece cover by pressing lightly on the bumps on the side. The strap on the mouthpiece cover will stay attached to the inhaler.
3. Hold the inhaler upright. Then press the counter (on the top of the inhaler) to release a puff into the air. You can use one or both hands, as shown in the pictures.
4. Release your finger(s) from the counter.
5. Wait for 10 seconds, shake well and then repeat steps 3 and 4.
6. Your inhaler is now ready for use.
Each time you need to take an inhalation, follow the instructions below:
1. Shake the inhaler well for at least 5 seconds to mix the contents of the aerosol canister.
2. Remove the mouthpiece cover by pressing lightly on the bumps on the side. Check that the mouthpiece is not blocked.
3. Hold your inhaler upright (using one or both hands). Breathe out gently.
4. Place the mouthpiece gently between your teeth. Close your lips.
5. Start to breathe in slowly and deeply through your mouth. Press the counter (on the top of the inhaler) firmly to release a puff. Keep breathing in for a short while after pressing the counter. Breathing in at the same time as pressing the counter ensures that the medicine reaches your lungs.
6. Hold your breath for 10 seconds, or for as long as it is comfortable.
7. Before you breathe out, release your finger from the counter and remove the inhaler from your mouth. Keep the inhaler upright.
8. Then breathe out slowly. To take another inhalation, shake the inhaler well for at least 5 seconds and repeat steps 3 to 7.
9. Replace the mouthpiece cover.
10. Rinse your mouth with water after your daily morning and evening doses and spit it out.
Your doctor, nurse or pharmacist may suggest that you use a spacer device (e.g. AeroChamber Plus Flow Vu or AeroChamber Plus). Follow the instructions in the leaflet that is packed with the spacer device.
If you use more Symbicort than you should, contact your doctor or pharmacist for advice. The following effects may happen: trembling, headache or a rapid heartbeat.
Before you stop using Symbicort, you should talk to your doctor or your pharmacist. If you stop using Symbicort the signs and symptoms of COPD may worsen.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common (may affect up to 1 in 10 people)
Tell your doctor if you have any of the following while taking Symbicort, they could be symptoms of a lung infection:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Inhaled corticosteroids can affect the normal production of steroid hormones in your body, particularly if you use high doses for a long time. The effects include:
These effects are much less likely to happen with inhaled corticosteroids than with corticosteroid tablets.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Warning: The canister contains a pressurised liquid. Do not expose to temperatures higher than 50°C. Do not pierce the canister. The canister should not be broken, punctured or burnt, even when it seems empty.
The active substances are budesonide and formoterol fumarate dihydrate. Each puff (actuation) contains 200 micrograms of budesonide and 6 micrograms of formoterol fumarate dihydrate.
The other ingredients are apaflurane (HFA 227), povidone and macrogol. This is a CFC-free inhaler.
Symbicort is an inhaler containing your medicine. The pressurised canister, with attached dose indicator, contains a white suspension for inhalation. The canister is fitted into a red plastic actuator with a white plastic mouthpiece and an integrated grey plastic dust cap. Each inhaler contains 120 puffs (actuations) after it has been prepared for use. Each inhaler is individually packed in a foil wrapper containing a drying agent.
Symbicort, 200 micrograms/6 micrograms/actuation pressurised inhalation, suspension (Budesonide/Formoterol fumarate dihydrate) is available in packs of one inhaler.
The Marketing Authorisation for Symbicort is held by
Symbicort is manufactured by
This medicinal product is authorised in the Member States of the EEA under the following names:
Country Trade name and strength
Austria Symbicort 160 Mikrogramm /4,5 Mikrogramm/Inhalation Druckgasinhalation, Suspension
Belgium Symbicort 160 microgram /4,5 microgram/inhalatie, aërosol, suspensie
Symbicort 160 microgrammes /4,5 microgrammes/inhalation, suspension pour inhalation en flacon pressurisé
Symbicort 160 Mikrogramm /4,5 Mikrogramm/Inhalation, Druckgasinhalation, Suspension
Bulgaria Симбикорт 160 микрограма /4,5 микрограма/впръскване
Суспензия под налягане за инхалация
Croatia Symbicort 160 mikrograma /4,5 mikrograma po potisku, stlačeni inhalat, suspenzija
Cyprus Symbicort 160 μικρογραμμάρια /4,5 μικρογραμμάρια/ψεκασμό
Czech Republic Symbicort 160 micrograms /4,5 micrograms/inhalation, suspension in pMDI
Denmark Symbicort 160 mikrogram /4.5 mikrogram/inhalation
Estonia Symbicort
Finland Symbicort 160 mikrog /4.5 mikrog/inhalaatio
France Symbicort 200/6 micro grammes par inhalation, suspension pour inhalation en flacon préssurisé
Germany Symbicort 160 Mikrogramm /4,5 Mikrogramm pro Inhalation
Druckgasinhalation, Suspension
Greece Symbicort 160 μικρογραμμάρια /4,5 μικρογραμμάρια/ψεκασμό
Hungary Symbicort 4,5 mikrogramm /160 mikrogramm/ adag túlnyomásos inhalációs szuszpenzió
Iceland Symbicort 160 míkrógrömm /4,5 míkrógrömm/ inhalation
Ireland Symbicort 200 micrograms /6 micrograms/inhalation
Italy Symbicort
Latvia Symbicort 160 mikrogrami /4.5 mikrogrami/ inhalācijā, izsmidzinājumā, aerosols inhalācijām zem spiediena
Lithuania Symbicort 160 mikrogramų/4,5 mikrogramo/išpurškime suslėgtoji įkvepiamoji suspensija
Luxembourg Symbicort 160 microgrammes /4,5 microgrammes/inhalation, suspension pour inhalation en flacon pressurisé
Malta Symbicort 200 micrograms /6 micrograms/inhalation
Netherlands Symbicort aërosol 200/6, 200 microgram /6 microgram per dosis, aërosol, suspensie
Norway Symbicort 160 mikrogram /4.5 mikrogram/ inhalasjon
Poland Symbicort
Portugal Symbicort 160 microgramas /4,5 microgramas/inalação
Suspensão pressurizada para inalação
Romania Symbicort 160 micrograme /4.5 micrograme/inhalaţie, suspensie de inhalat presurizată
Slovakia Symbicort 160 mikrogamov /4,5 mikrogamov/inhalačná dávka, inhalačná suspenzia v tlakovom obale
Slovenia Symbicort 160 mikrogramov /4,5 mikrograma na vdih, inhalacijska suspenzija pod tlakom
Spain Symbicort 160 microgramos /4,5 microgramos/inhalación suspensión para inhalación en envase a presión
Sweden Symbicort 160 mikrogram /4.5 mikrogram/inhalation
United Kingdom Symbicort 200 micrograms/6 micrograms per actuation pressurised inhalation, suspension
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
Product name Symbicort 200/6
Reference number 17901/0293
This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in October 2022.
© AstraZeneca 2022
Symbicort is a trademark of the AstraZeneca group of companies.
RSP 22 0103
2 Pancras Square, 8th Floor, London, N1C 4AG, UK
+44 (0)1582 838 000
www.myazmed.co.uk
+44 (0)1582 836 000
0800 783 0033
https://medicalinformation.astrazeneca.co.uk/